CymitQuimica logo
Angiogénesis

Angiogénesis

Los inhibidores de la angiogénesis son compuestos que interfieren con la formación de nuevos vasos sanguíneos, un proceso crucial en el crecimiento y la metástasis del cáncer. Al inhibir la angiogénesis, estos compuestos pueden restringir el suministro de sangre a los tumores, ralentizando o deteniendo su crecimiento. Los inhibidores de la angiogénesis son esenciales en la investigación del cáncer y en el desarrollo terapéutico, proporcionando información sobre los mecanismos de progresión tumoral y ofreciendo posibles tratamientos para el cáncer y otras enfermedades relacionadas con la angiogénesis. En CymitQuimica, ofrecemos una amplia gama de inhibidores de la angiogénesis de alta calidad para apoyar su investigación en oncología y biología vascular.

Subcategorías de "Angiogénesis"

Mostrar 6 subcategorías más

Se han encontrado 1483 productos de "Angiogénesis"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • NX-5948

    CAS:
    <p>NX-5948 (BTK-IN-24) is a PROTAC-type BTK degrader with anti-inflammatory and anticancer activities, inhibiting B cell activation.</p>
    Fórmula:C42H54N12O5
    Pureza:98.29%
    Forma y color:Solid
    Peso molecular:806.96
  • LDN-193189 Tetrahydrochloride

    CAS:
    <p>LDN193189 is a BMPI receptor inhibitor, blocking ALK2 and ALK3 effectively, while weak on ALK4, ALK5, ALK7.</p>
    Fórmula:C25H26Cl4N6
    Pureza:98.21%
    Forma y color:Solid
    Peso molecular:552.33
  • Lanraplenib succinate

    CAS:
    Lanraplenib succinate is an oral SYK inhibitor (IC50=9.5 nM) that doesn't extend BT, targeting GPVI in platelets for inflammation treatment.
    Fórmula:C58H68N18O14
    Forma y color:Solid
    Peso molecular:1241.294
  • Bleximenib oxalate

    CAS:
    <p>Bleximenib oxalate (Menin-MLL inhibitor 24 oxalate) is a menin-MLL inhibitor that blocks the binding of the menin-KMT2A complex to chromatin at gene promoters.</p>
    Fórmula:C34H52FN7O7
    Pureza:98%
    Forma y color:Solid
    Peso molecular:689.82
  • Tirbanibulin dihydrochloride

    CAS:
    <p>Tirbanibulin is an inhibitor of Src that targets the peptide substrate site of Src (GI50: 9-60 nM in cancer cell lines).</p>
    Fórmula:C26H31Cl2N3O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:504.45
  • Cediranib maleate

    CAS:
    <p>Cediranib maleate (AZD2171 maleate) is a VEGFR2 inhibitor that inhibits Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit.</p>
    Fórmula:C29H31FN4O7
    Forma y color:Solid
    Peso molecular:566.58
  • Pentagamavunon-1

    CAS:
    <p>PGV-1, an oral Curcumin analog, induces apoptosis by inhibiting COX-2, VEGF, and NF-κB activation.</p>
    Fórmula:C23H24O3
    Forma y color:Solid
    Peso molecular:348.43
  • N-piperidine Ibrutinib hydrochloride

    CAS:
    <p>N-piperidine Ibrutinib hydrochloride is a BTK inhibitor that inhibits WT BTK and C481S BTK , which inhibits the growth and proliferation of cancer cells.</p>
    Fórmula:C22H23ClN6O
    Pureza:98.83%
    Forma y color:Solid
    Peso molecular:422.91
  • Iruplinalkib

    CAS:
    <p>Iruplinalkib (WX-0593) is an orally active, selective and potent ALK and ROS1 tyrosine kinase inhibitor with anticancer activity for use in the study of non-small cell lung cancer.</p>
    Fórmula:C29H38ClN6O2P
    Pureza:97.38%
    Forma y color:Solid
    Peso molecular:569.08
  • Rociletinib hydrobromide

    CAS:
    Rociletinib hydrobromide is an orally delivered inhibitor of the mutant form of EGFR kinase (Kis: 21.5 nM and 303.3 nM for EGFR L858R/T790M and EGFR WT).
    Fórmula:C27H29BrF3N7O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:636.46
  • Surfen dihydrochloride

    CAS:
    <p>Surfen dihydrochloride (Aminoquinuride dihydrochloride) is a heparin sulfate antagonist with antimicrobial properties and inhibits blockade of signaling.</p>
    Fórmula:C21H22Cl2N6O
    Pureza:97.08%
    Forma y color:Solid
    Peso molecular:445.35
  • Gefitinib-d8

    CAS:
    <p>Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib D8 is a deuterium labeled Gefitinib.</p>
    Fórmula:C22H24ClFN4O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:454.95
  • Erlotinib-d6

    CAS:
    <p>Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib .</p>
    Fórmula:C22H23N3O4
    Pureza:98%
    Forma y color:Solid
    Peso molecular:399.47
  • Ribociclib-d6

    CAS:
    <p>Ribociclib-d6 is a deuterated compound of Ribociclib (LEE011) for isotope tracing.Ribociclib is an orally available CDK4/6 inhibitor with antitumor activity.</p>
    Fórmula:C23H30N8O
    Forma y color:Solid
    Peso molecular:440.57
  • Poseltinib

    CAS:
    <p>Poseltinib is an oral, irreversible BTK inhibitor (IC50 1.95 nM) with higher selectivity over BMX, TEC, and TXK, blocking BCR, FcR, and TLR signaling.</p>
    Fórmula:C26H26N6O3
    Forma y color:Solid
    Peso molecular:470.52
  • EW-7195

    CAS:
    <p>EW-7195 inhibits ALK5/TGFβR1 (&gt;300x selective over p38α) with 4.83 nM IC50, blocking TGF-β1 signaling, EMT, and breast cancer lung metastasis.</p>
    Fórmula:C23H18N8
    Pureza:98.76%
    Forma y color:Solid
    Peso molecular:406.44
  • Elsubrutinib

    CAS:
    <p>Elsubrutinib (ABBV-105) is a highly active, potent, and selective orally-administered inhibitor of Bruton's tyrosine kinase (BTK). It irreversibly inhibits the catalytic domain of BTK with an IC50 value of 0.18 μM. Elsubrutinib holds potential for the advancement of research on inflammatory diseases.</p>
    Fórmula:C17H19N3O2
    Forma y color:Solid
    Peso molecular:297.358
  • Disitamab

    CAS:
    <p>Disitamab (RC48-0) is a humanized anti-HER2 monoclonal antibody used in ADC synthesis.</p>
    Pureza:95.00%
    Forma y color:Liquid
  • Aflibercept

    CAS:
    <p>Aflibercept has a wide range of applications in life science related research.</p>
    Forma y color:Liquid
  • Conteltinib tetrahydrochloride


    <p>Conteltinibtetrahydrochloride (CT-707 tetrahydrochloride) is the tetrahydrochloride form of Conteltinib. It acts as an inhibitor for FAK (IC50=1.6 nM), ALK, and Pyk2. When used in combination with Cabozantinib, Conteltinib tetrahydrochloride exhibits a synergistic antitumor effect.</p>
    Fórmula:C32H49Cl4N9O3S
    Forma y color:Solid
    Peso molecular:781.667